ISTH 2022 | Intramuscular COVID-19 vaccination in patients with severe hemophilia A

Name: Intramuscular COVID-19 vaccination in patients with severe hemophilia A
Uploaded: 2022-07-11T00:00:00Z
Duration: 51 s
Description: Susan Halimeh, MD, Gerinnungszentrum Rhein-Ruhr, Duisburg, Germany, briefly discusses the results of a study that showed that COVID-19 vaccines could be administered via intramuscular injection in patients with severe hemophilia A. This interview took place at the 30th Congress of the International Society on Thrombosis and Haemostasis (ISTH) 2022 held in London, UK.

Susan Halimeh • 11 Jul 2022

ISTH 2022

Hemophilia Vaccines

Susan Halimeh, MD, Gerinnungszentrum Rhein-Ruhr, Duisburg, Germany, briefly discusses the results of a study that showed that COVID-19 vaccines could be administered via intramuscular injection in patients with severe hemophilia A. This interview took place at the 30th Congress of the International Society on Thrombosis and Haemostasis (ISTH) 2022 held in London, UK.